Kevin Welch


Kevin is the Executive Chairman of AXCS Capital. Kevin is an experienced and successful entrepreneur with a demonstrated track record of growing technology driven companies from inception to multi-billion-dollar entities. Kevin recently created, spun-out & sold RedSail Technologies to a private equity sponsor and in doing so created the largest provider of information systems and data services in the pharmaceutical technology sector. Prior to the RedSail, Kevin was president of Smith Technologies (representing the QS/1®, Integra®, PUBLIQTM, and PowerLineTM brands) and Chief Technical Officer of the J M Smith Corporation, a large multi-billion-dollar company and the 4th largest drug distributor in the US.

Prior to Smith Technologies, Kevin was CEO of Integra which he founded and sold. Prior to Integra, Kevin was president of Shared Healthcare System (sold to OmniCare), CTO of Sun Healthcare Systems (one of the largest public senior healthcare providers), Director of R&D of Symantec Corporation (SYMC), and a Research scientist at Genetech (sold to Roche). Kevin holds degrees in mathematics, computer science, operations research and engineering management from Stanford University.